251 related articles for article (PubMed ID: 28241245)
21. How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.
Germans T; Rüssel IK; Götte MJ; Spreeuwenberg MD; Doevendans PA; Pinto YM; van der Geest RJ; van der Velden J; Wilde AA; van Rossum AC
J Cardiovasc Magn Reson; 2010 Mar; 12(1):13. PubMed ID: 20230637
[TBL] [Abstract][Full Text] [Related]
22. Hypertrophic cardiomyopathy: preclinical and early phenotype.
Ho CY
J Cardiovasc Transl Res; 2009 Dec; 2(4):462-70. PubMed ID: 20560004
[TBL] [Abstract][Full Text] [Related]
23. Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation.
Sipola P; Magga J; Husso M; Jääskeläinen P; Peuhkurinen K; Kuusisto J
Eur Radiol; 2011 Jul; 21(7):1383-9. PubMed ID: 21274714
[TBL] [Abstract][Full Text] [Related]
24. Multilayer Myocardial Mechanics in Genotype-Positive Left Ventricular Hypertrophy-Negative Patients With Hypertrophic Cardiomyopathy.
Williams LK; Misurka J; Ho CY; Chan WX; Agmon Y; Seidman C; Rakowski H; Carasso S
Am J Cardiol; 2018 Nov; 122(10):1754-1760. PubMed ID: 30249441
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations.
Pöyhönen P; Hiippala A; Ollila L; Kaasalainen T; Hänninen H; Heliö T; Tallila J; Vasilescu C; Kivistö S; Ojala T; Holmström M
J Cardiovasc Magn Reson; 2015 Oct; 17():89. PubMed ID: 26496977
[TBL] [Abstract][Full Text] [Related]
26. Discrepant Measurements of Maximal Left Ventricular Wall Thickness Between Cardiac Magnetic Resonance Imaging and Echocardiography in Patients With Hypertrophic Cardiomyopathy.
Hindieh W; Weissler-Snir A; Hammer H; Adler A; Rakowski H; Chan RH
Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794137
[TBL] [Abstract][Full Text] [Related]
27. Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-Guided Electrocardiography.
Joy G; Lopes LR; Webber M; Ardissino AM; Wilson J; Chan F; Pierce I; Hughes RK; Moschonas K; Shiwani H; Jamieson R; Velazquez PP; Vijayakumar R; Dall'Armellina E; Macfarlane PW; Manisty C; Kellman P; Davies RH; Tome M; Koncar V; Tao X; Guger C; Rudy Y; Hughes AD; Lambiase PD; Moon JC; Orini M; Captur G
J Am Coll Cardiol; 2024 Mar; 83(11):1042-1055. PubMed ID: 38385929
[TBL] [Abstract][Full Text] [Related]
28. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
[TBL] [Abstract][Full Text] [Related]
29. Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy.
Joy G; Kelly CI; Webber M; Pierce I; Teh I; McGrath L; Velazquez P; Hughes RK; Kotwal H; Das A; Chan F; Bakalakos A; Lorenzini M; Savvatis K; Mohiddin SA; Macfarlane PW; Orini M; Manisty C; Kellman P; Davies RH; Lambiase PD; Nguyen C; Schneider JE; Tome M; Captur G; Dall'Armellina E; Moon JC; Lopes LR
Circulation; 2023 Sep; 148(10):808-818. PubMed ID: 37463608
[TBL] [Abstract][Full Text] [Related]
30. Intrinsic mitral valve alterations in hypertrophic cardiomyopathy sarcomere mutation carriers.
Groarke JD; Galazka PZ; Cirino AL; Lakdawala NK; Thune JJ; Bundgaard H; Orav EJ; Levine RA; Ho CY
Eur Heart J Cardiovasc Imaging; 2018 Oct; 19(10):1109-1116. PubMed ID: 30052928
[TBL] [Abstract][Full Text] [Related]
31. Distinguishing left ventricular hypertrophy from hypertrophic cardiomyopathy in adolescents: a longitudinal observation study.
Forså MI; Smedsrud MK; Haugaa KH; Bjerring AW; Früh A; Sarvari SI; Landgraff HW; Hallén J; Edvardsen T
Eur J Prev Cardiol; 2024 Mar; 31(5):591-598. PubMed ID: 37992187
[TBL] [Abstract][Full Text] [Related]
32. Vigorous exercise in patients with hypertrophic cardiomyopathy.
Dejgaard LA; Haland TF; Lie OH; Ribe M; Bjune T; Leren IS; Berge KE; Edvardsen T; Haugaa KH
Int J Cardiol; 2018 Jan; 250():157-163. PubMed ID: 29169752
[TBL] [Abstract][Full Text] [Related]
33. Global and regional echocardiographic strain to assess the early phase of hypertrophic cardiomyopathy due to sarcomeric mutations.
Baudry G; Mansencal N; Reynaud A; Richard P; Dubourg O; Komajda M; Isnard R; Réant P; Charron P
Eur Heart J Cardiovasc Imaging; 2020 Mar; 21(3):291-298. PubMed ID: 31056691
[TBL] [Abstract][Full Text] [Related]
34. Spirito-Maron echocardiographic score: a marker for morphological and physiological assessment of patients with hypertrophic cardiomyopathy.
Rangel I; Gonçalves A; de Sousa C; Correia AS; Pinho T; Madureira AJ; Martins E; Cardoso JS; Macedo F; Maciel MJ
Echocardiography; 2014 Jul; 31(6):708-15. PubMed ID: 24460546
[TBL] [Abstract][Full Text] [Related]
35. Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.
Forsey J; Benson L; Rozenblyum E; Friedberg MK; Mertens L
J Am Soc Echocardiogr; 2014 Feb; 27(2):215-21. PubMed ID: 24325958
[TBL] [Abstract][Full Text] [Related]
36. Right ventricular myocardial diastolic dysfunction in different kinds of cardiac hypertrophy: analysis by pulsed Doppler tissue imaging.
Galderisi M; Severino S; Caso P; Cicala S; Petrocelli A; De Simone L; Mininni N; de Divitiis O
Ital Heart J; 2001 Dec; 2(12):912-20. PubMed ID: 11838339
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of left ventricular end diastolic pressure using E/E' in patients with hypertrophic cardiomyopathy.
Badran HM; Soltan G; Almeleigi R; Faheem N; Yacoub MH
Echocardiography; 2019 Dec; 36(12):2167-2175. PubMed ID: 31742769
[TBL] [Abstract][Full Text] [Related]
38. CMR derived left ventricular septal convexity in carriers of the hypertrophic cardiomyopathy-causing MYBPC3-Q1061X mutation.
Tarkiainen M; Sipola P; Jalanko M; Heliö T; Jääskeläinen P; Kivelä K; Laine M; Lauerma K; Kuusisto J
Sci Rep; 2019 Apr; 9(1):5960. PubMed ID: 30976029
[TBL] [Abstract][Full Text] [Related]
39. Echocardiographic characteristics of PRKAG2 syndrome: a research using three-dimensional speckle tracking echocardiography compared with sarcomeric hypertrophic cardiomyopathy.
Tang L; Li X; Zhou N; Jiang Y; Pan C; Shu X
Cardiovasc Ultrasound; 2022 May; 20(1):14. PubMed ID: 35509080
[TBL] [Abstract][Full Text] [Related]
40. Clinical Profile of Athletes With Hypertrophic Cardiomyopathy.
Sheikh N; Papadakis M; Schnell F; Panoulas V; Malhotra A; Wilson M; Carré F; Sharma S
Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003454. PubMed ID: 26198026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
